2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
3/15/2022 | 12:00 PM - 1:00 PM | The Utah Cytomegalovirus (CMV) Mandate...Eight Years Later | Room 2
The Utah Cytomegalovirus (CMV) Mandate...Eight Years Later
In 2013 Utah became the first state in the nation to mandate hearing-directed cytomegalovirus (CMV) testing for all infants who fail the “newborn hearing screening test(s)” before 21 days of age. The rule written to accompany the law clarified eligibility by stating that eligible infants are those who fail both the initial hearing screen routinely done at birth and the subsequent follow-up screen OR when the initial failed hearing screen is obtained after 14 days of age. There was also a clause pertaining to Special Populations of Newborns whom testing for CMV is left to the discretion of the medical practitioner(s) caring for the newborn. These different eligibility categories, ever-evolving protocols, along with large data collection and stakeholder education needs all contributed to what seemed like daunting tasks at the beginning, yet eight years later, more than just mandate-targeted newborns are receiving CMV testing. Come learn challenges we faced and how we overcame them; the growth in partnerships and protocols leading to increased testing; how our CMV testing mandate improved our EHDI program; strategies for a successful newborn hearing screening-targeted CMV testing program; and important outcomes.
- Describe how the Utah CMV testing mandate has grown over the years
- Identify key steps necessary in ensuring a successful CMV testing mandate
- Discuss potential barriers to timely CMV testing and ways to overcome them
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Stephanie Browning McVicar
(Primary Presenter,Author), Utah Department of Health and Human Services, smcvicar@utah.gov;
Dr. Stephanie Browning McVicar is the Director of the Early Hearing Detection and Intervention Program, the Children’s Hearing Aid Program, and the Cytomegalovirus (CMV) Public Health Initiative in Utah. She works for the Utah Department of Health and Human Services' Children with Special Health Care Needs Office in Salt Lake City. Dr. McVicar is a pediatric audiologist, an advocate for CMV testing in newborns, and passionate about the prevention of congenital CMV infection. She was instrumental in the creation of the Utah EHDI tele-audiology program. She is originally from Western New York and has extensive experience and knowledge in Audiology and the management of health care programs in both the public and private sectors.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exists.
Nonfinancial -
No relevant nonfinancial relationship exists.
AAA DISCLOSURE:
Financial -
No relevant financial relationship exists.
Nonfinancial -
No relevant nonfinancial relationship exists.